1106
While the patient was receiving both drugs, platelet aggregation studies revealed less platelet inhibition than would be expected in a patient not taking a concomitant inducer of ticagrelor metabolism.
 a patient: Subject; less platelet inhibition than would be expected: Effect; taking a concomitant inducer of ticagrelor metabolism.: Treatment; ticagrelor: Treatment.Drug; inducer of ticagrelor metabolism: Treatment.Drug; inducer of ticagrelor metabolism: Combination.Drug; ticagrelor: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a patient: Subject; less platelet inhibition than would be expected: Effect; taking a concomitant inducer of ticagrelor metabolism.: Treatment; ticagrelor: Treatment.Drug; inducer of ticagrelor metabolism: Treatment.Drug; inducer of ticagrelor metabolism: Combination.Drug; ticagrelor: Combination.Drug